These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Modulation of endothelial cell function by antiphospholipid antibodies. Meroni PL; Del Papa N; Beltrami B; Tincani A; Balestrieri G; Krilis SA Lupus; 1996 Oct; 5(5):448-50. PubMed ID: 8902779 [TBL] [Abstract][Full Text] [Related]
8. Endothelium as a target for antiphospholipid antibodies. Riboldi P; Gerosa M; Raschi E; Testoni C; Meroni PL Immunobiology; 2003; 207(1):29-36. PubMed ID: 12638900 [TBL] [Abstract][Full Text] [Related]
9. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004 [TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro. Di Simone N; Raschi E; Testoni C; Castellani R; D'Asta M; Shi T; Krilis SA; Caruso A; Meroni PL Ann Rheum Dis; 2005 Mar; 64(3):462-7. PubMed ID: 15256379 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease? Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152 [TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of the antiphospholipid antibody syndrome: an update. Singh AK Curr Opin Nephrol Hypertens; 2001 May; 10(3):355-8. PubMed ID: 11342797 [TBL] [Abstract][Full Text] [Related]
13. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
14. Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Meroni PL; Raschi E; Testoni C; Tincani A; Balestrieri G; Molteni R; Khamashta MA; Tremoli E; Camera M Arthritis Rheum; 2001 Dec; 44(12):2870-8. PubMed ID: 11762948 [TBL] [Abstract][Full Text] [Related]
15. The clinical significance of antiphospholipid antibodies. Martini A; Ravelli A Ann Med; 1997 Apr; 29(2):159-63. PubMed ID: 9187233 [TBL] [Abstract][Full Text] [Related]
16. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. Patterson AM; Ford I; Graham A; Booth NA; Greaves M Br J Haematol; 2006 May; 133(3):323-30. PubMed ID: 16643435 [TBL] [Abstract][Full Text] [Related]
17. Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells. Le Tonquèze M; Salozhin K; Dueymes M; Piette JC; Kovalev V; Shoenfeld Y; Nassonov E; Youinou P Lupus; 1995 Jun; 4(3):179-86. PubMed ID: 7655487 [TBL] [Abstract][Full Text] [Related]